EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study

Milo Gatti iD, Matteo Rinaldi, Cristiana Laici, Cecilia Bonazzetti iD, Luca Vizioli, Simone Ambretti, Maria Cristina Morelli iD, Antonio Siniscalchi, Maddalena Giannella, Pierluigi Viale, Federico Pea iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf048 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Milo Gatti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Liver Transplantation, beta-Lactams, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the impact of attaining aggressive β-lactam (BL) pharmacokinetic-pharmacodynamic (PK/PD) targets on clinical efficacy in critically ill orthotopic liver transplant (OLT) recipients with documented early gram-negative infections.

Methods

The study prospectively enrolled OLT recipients admitted to the posttransplant intensive care unit between June 2021 and May 2024; they had documented gram-negative infections treated with targeted therapy continuous infusion (CI) BLs and underwent therapeutic drug monitoring (TDM)-guided BL dosing adjustment within the first 72 hours. Aggressive PK/PD target attainment was measured. Multivariate logistic regression analyses were performed to test independent variables associated with 30-day resistance occurrence.

Results

Fifty critically ill OLT recipients were treated with CI BL in monotherapy (n = 34) or combination (n = 16) therapy for documented gram-negative infections No significant difference in clinical/microbiological outcome emerged between monotherapy and combination therapy. In 4 patients (8.0%), resistance developed within 30 days. At multivariate analysis, failure in attaining an aggressive BL PK/PD target emerged as the only independent predictor of 30-day resistance development (odds ratio, 14.33 [95% confidence interval, 1.46–140.53]; P = .02).

Conclusions

Attaining an aggressive PK/PD target with CI BLs in critically ill OLT recipients with documented gram-negative infections could represent an effective strategy for minimizing resistance occurrence to the selected BL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Transplantationbeta-LactamsGram-Negative Bacterial InfectionsAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedCritical IllnessProspective StudiesAgedAdultDrug MonitoringTreatment OutcomeTransplant RecipientsInfusions, Intravenous

Stichwörter der Autor:innen

Critically ill OLT recipientscontinuous infusion β-lactamsearly gram-negative infectionspharmacokinetic-pharmacodynamic target attainmentresistance development

Substanzen

beta-LactamsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Infectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Division of Anesthesiology, Department of Anesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Internal Medicine Unit for the treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Operative Unit of Microbiology, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

ORCID-Profile: Milo Gatti, Cecilia Bonazzetti, Maria Cristina Morelli, Federico Pea

Förderung

  • Italian Ministry of Health

Zitieren

APA

Gatti, M., Rinaldi, M., Laici, C., Bonazzetti, C., Vizioli, L., Ambretti, S., Morelli, M. C., Siniscalchi, A., Giannella, M., Viale, P., & Pea, F. (2025). Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf048

Vancouver

Gatti M, Rinaldi M, Laici C, Bonazzetti C, Vizioli L, Ambretti S, et al. Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf048

BibTeX
@article{Gatti2025,
  author = {Gatti, Milo and Rinaldi, Matteo and Laici, Cristiana and Bonazzetti, Cecilia and Vizioli, Luca and Ambretti, Simone and Morelli, Maria Cristina and Siniscalchi, Antonio and Giannella, Maddalena and Viale, Pierluigi and Pea, Federico},
  title = {Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf048}
}
Kostenlos starten →